Patient-important outcomes reported in randomized controlled trials of pharmacologic treatments for COVID-19: a protocol of a META-epidemiological study
Abstract Background The coronavirus disease 19 (covid-19) pandemic has underscored the need to expedite clinical research, which may lead investigators to shift away from measuring patient-important outcomes (PIO), limiting research applicability. We aim to investigate if randomized controlled trial...
Guardado en:
Autores principales: | Mario A. Jimenez-Mora, Andrea Ramírez Varela, Jose F. Meneses-Echavez, Julia Bidonde, Adriana Angarita-Fonseca, Reed A. C. Siemieniuk, Dena Zeraatkar, Jessica J. Bartoszko, Romina Brignardello-Petersen, Kimia Honarmand, Bram Rochwerg, Gordon Guyatt, Juan José Yepes-Nuñez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ad1c46a4def4d14a7cd3c8366c1070a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Síndrome respiratorio agudo severo
por: Wu H.,Elba
Publicado: (2003) -
Oral Manifestation COVID-19 and the Rapid Resolution of Symptoms Post-Phtalox Treatment: a Case Series
por: Orcina,Bernardo da Fonseca, et al.
Publicado: (2021) -
Salud mental en trabajadores de la salud durante la pandemia por COVID-19 en Chile
por: Urzúa,Alfonso, et al.
Publicado: (2020) -
La toma de decisiones de gobiernos y sectores de la sociedad, intuiciones y datos en tiempos de pandemia SARS-COVID-19
por: Alida María Acosta Ortiz
Publicado: (2020) -
Low Cost Equipment with Compressor System and Balanced Pressure to Protect the Professional Dentist Against Contaminated Aerosol During COVID-19 Pandemic
por: Vieira,José Custódio Feres
Publicado: (2020)